Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC   MYLAN
EQUITY SHARE DATA
    ALEMBIC
Mar-23
MYLAN
Dec-18
ALEMBIC/
MYLAN
5-Yr Chart
Click to enlarge
High Rs873,967-   
Low Rs562,184-   
Sales per share (Unadj.) Rs5.01,825.4-  
Earnings per share (Unadj.) Rs3.149.6-  
Cash flow per share (Unadj.) Rs3.4391.3-  
Dividends per share (Unadj.) Rs2.200-  
Avg Dividend yield %3.10-  
Book value per share (Unadj.) Rs80.91,974.7-  
Shares outstanding (eoy) m256.78514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x14.41.7 853.6%   
Avg P/E ratio x22.762.0 36.6%  
P/CF ratio (eoy) x21.07.9 266.6%  
Price / Book Value ratio x0.91.6 56.5%  
Dividend payout %70.10-   
Avg Mkt Cap Rs m18,2981,582,214 1.2%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m2400-   
Avg. sales/employee Rs Th026,833.1-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0728.6-  
INCOME DATA
Net Sales Rs m1,272939,158 0.1%  
Other income Rs m6430-   
Total revenues Rs m1,915939,158 0.2%   
Gross profit Rs m297243,019 0.1%  
Depreciation Rs m67175,847 0.0%   
Interest Rs m545,170 0.0%   
Profit before tax Rs m86822,002 3.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m62-3,500 -1.8%   
Profit after tax Rs m80625,502 3.2%  
Gross profit margin %23.425.9 90.3%  
Effective tax rate %7.1-15.9 -44.7%   
Net profit margin %63.42.7 2,333.3%  
BALANCE SHEET DATA
Current assets Rs m1,721524,425 0.3%   
Current liabilities Rs m838382,364 0.2%   
Net working cap to sales %69.415.1 458.9%  
Current ratio x2.11.4 149.7%  
Inventory Days Days5,03884 6,029.2%  
Debtors Days Days67393 720.9%  
Net fixed assets Rs m20,324182,181 11.2%   
Share capital Rs m514500 102.7%   
"Free" reserves Rs m20,2670-   
Net worth Rs m20,7801,015,998 2.0%   
Long term debt Rs m01,096,588 0.0%   
Total assets Rs m22,0462,725,301 0.8%  
Interest coverage x187.71.5 12,619.5%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.10.3 16.7%   
Return on assets %3.72.6 141.8%  
Return on equity %3.92.5 154.6%  
Return on capital %4.23.2 132.1%  
Exports to sales %1.20-   
Imports to sales %2.40-   
Net fx Rs m-140-   
CASH FLOW
From Operations Rs m389195,157 0.2%  
From Investments Rs m73-100,875 -0.1%  
From Financial Activity Rs m-464-90,916 0.5%  
Net Cashflow Rs m-21,617 -0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare ALEMBIC With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ALEMBIC With: DISHMAN CARBOGEN AMCIS  AMRUTANJAN HEALTHCARE  ALCHEMIST LIMITED  BIOCON   GLAND PHARMA  



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.